Evidence map›Paper›PMID 30076358›Full record

ArticleNature communications2018

Genomic instability in mutant p53 cancer cells upon entotic engulfment.

Hannah L Mackay, David Moore, Callum Hall, Nicolai J Birkbak, Mariam Jamal-Hanjani, Saadia A Karim, Vinaya M Phatak, Lucia Piñon, Jennifer P Morton, Charles Swanton and 2 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 70 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 1 synthesis or guideline pooled it, 108 citations in OpenAlex.

  1. Pooled it
  2. Programmed cell death in lung cancer: mechanisms, immune responses, and therapeutics.Apoptosis : an international journal on programmed cell death · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Entosis in Health and Disease.Advances in experimental medicine and biology · 2025
    Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 1 country.

Hannah L MackayMRC Toxicology Unit, Lancaster Road, Leicester, LE1 9HN, UK.
David MooreMRC Toxicology Unit, Lancaster Road, Leicester, LE1 9HN, UK.
Callum HallCancer Research UK Manchester Institute, The University of Manchester | Alderley Park, Manchester, SK10 4TG, UK.
Nicolai J BirkbakTranslational Cancer Therapeutics Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.
Mariam Jamal-HanjaniDepartment of Medical Oncology, University College London Hospitals, 235 Euston Rd, Fitzrovia, London, NW1 2BU, UK.
Saadia A KarimInstitute of Cancer Sciences, University of Glasgow, Switchback Road, Glasgow, G61 1BD, UK.
Vinaya M PhatakMRC Toxicology Unit, Lancaster Road, Leicester, LE1 9HN, UK.
Lucia PiñonMRC Toxicology Unit, Lancaster Road, Leicester, LE1 9HN, UK.
Jennifer P MortonInstitute of Cancer Sciences, University of Glasgow, Switchback Road, Glasgow, G61 1BD, UK.
Charles SwantonTranslational Cancer Therapeutics Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.
John Le QuesneMRC Toxicology Unit, Lancaster Road, Leicester, LE1 9HN, UK. jlq2@le.ac.uk.
Patricia A J MullerMRC Toxicology Unit, Lancaster Road, Leicester, LE1 9HN, UK. patricia.muller@manchester.ac.uk.
MRC Toxicology Unit · GBCancer Research UK Manchester Institute · GBUniversity of Leicester · GBCancer Research UK Scotland Institute · GBGlenfield Hospital · GBThe Francis Crick Institute · GBUniversity College Hospital · GBUniversity of Glasgow · GB

Funding

Cancer Research UK 17786Cancer Research UK 20466Cancer Research UK 21999Medical Research Council MC_UP_1203/1Medical Research Council MC_UP_1203/3Wellcome TrustWellcome Trust WT101242AIA
6 · The paper itself

Abstract

Cell-in-cell (CIC) structures are commonly seen in tumours. Their biological significance remains unclear, although they have been associated with more aggressive tumours. Here we report that mutant p53 promotes CIC via live cell engulfment. Engulfed cells physically interfere in cell divisions of host cells and for cells without p53 this leads to host cell death. In contrast, mutant p53 host cells survive, display aberrant divisions, multinucleation and tripolar mitoses. In xenograft studies, CIC-rich p53 mutant/null co-cultures show enhanced tumour growth. Furthermore, our results show that CIC is common within lung adenocarcinomas, is an independent predictor of poor outcome and disease recurrence, is associated with mutant p53 expression and correlated to measures of heterogeneity and genomic instability. These findings suggest that pro-tumorigenic entotic engulfment activity is associated with mutant p53 expression, and the two combined are a key factor in genomic instability.

Indexed as

Genomic InstabilityAdenocarcinoma of LungAnimalsCarcinogenesisCell DeathCell-in-Cell FormationCell Line, TumorCell ProliferationDisease Models, AnimalDNA DamageHeterograftsHumansLung NeoplasmsMaleMiceMice, Inbred BALB CTP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID30076358
PMCPMC6076230
OpenAlexW2886717092

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.